Breaking News

PHILADELPHIA, Sept. 14 - NCI Director Richard Klausner announced on Tuesday that he will step down from his post on Sept.

CANNES, France, Sept. 13 - Ask bioethicist Arthur Caplan what's at the top of his wish list and he'll tell you: an in-house bioethicist in every genomic, bioinformatic, and microarray company worldwide within the next 10 years.

NEW YORK, Sept 11 – Microarray developer NimbleGen Systems of Madison, Wis., said Tuesday it had raised $9 million in a private round of financing. The company has raised more than $12.5 million in total.

NEW YORK, Sept 11 – AlphaGene of Woburn, Mass., said Tuesday it has signed an agreement with Wayne State University to study malignant brain tumor cell types using gene expression technology. Under the terms of the deal, AlphaGene will

NESS ZIONA, Israel, Sept 11 – Genomic research often amounts to looking for a needle in a haystack as researchers plow through vast amounts of data searching for clues that will implicate a gene’s or a protein’s role in disease. But at Quark Biotec

NEW YORK, Sept.

NEW YORK, Sept 10 – Incyte Genomics said Monday it had extended a deal with Galapagos Genomics of Mechelen, Belgium to further develop an adenoviral library for Incyte’s in-house drug development program. Under the terms of the agreemen

NEW YORK, Sept. 10 - Genops Bioinformatics signed an exclusive sales and marketing arrangement with Samsung Corp. for the Asia/Oceania market, the company announced Monday. Under the partnership, Samsung Corp.

NEW YORK, Sept. 10 – Amersham Pharmacia Biotech has licensed green fluorescent protein technology from Aurora Biosciences, the company announced Monday.

NEW YORK, Sept 10 – Atugen, a Berlin-based functional genomics company, said Monday that Arena Pharmaceuticals had agreed to evaluate its G-protein coupled receptor technology. Under the terms of the deal, Atugen’s US-based subsidiary w

NEW YORK, Sept 10 – Affymetrix said Monday that it had expanded its agreement to provide GlaxoSmithKline with its GeneChip technology.  Under the terms of the deal, Glaxo’s research centers will be able to receive customized GeneCh

NEW YORK, Sept. 7 – Proteomics and microarray developer Genomic Solutions said on Friday it plans to cut 25 percent of its workforce and restructure its business to help it become profitable by the first quarter of next year.

Like genomics, the field of proteomics reverses traditional methodologies of protein characterization. It comes as no surprise, then, that proteomics can expect problems similar to those faced when attempting to patent genomics inventions.

NEW YORK, Sept. 7 – Genops Bioinformatics and bioinformatics startup Zerosum plan to enter an information-sharing partnership to help Genops broaden its Ngene software and boost Zerosum’s burgeoning business, the companies said this week.

NEW YORK, Sept.

NEW YORK, Sept. 6 – Gene Logic has licensed a pair of its technology platforms and a set of gene targets to a business unit of Belgian drug company UCB Pharma, the companies said on Thursday.

NEW YORK, Sept. 6 – BioBridge Computing has finished developing its PIUMS protein identification software and has delivered the first unit to its research partner AstraZeneca, GenomeWeb has learned.

That Intangible Thing

SAN FRANCISCO, Sept. 6 – There is a Hindu tenet that says that destruction is needed for creation to begin.

SAN FRANCISCO, Sept. 6 - Structural Genomix has committed to buy $2 million to $3 million worth of equipment from Compaq and to explore a longer-term strategic relationship with the firm, both companies told GenomeWeb .

NEW YORK, Sept.

Pages

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.